William B. Hayes - 10 Jun 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Director
Signature
/s/ William B. Hayes
Issuer symbol
INDP
Transactions as of
10 Jun 2025
Net transactions value
$0
Form type
4
Filing time
11 Jun 2025, 16:05:15 UTC
Previous filing
03 Jun 2025
Next filing
03 Sep 2025

Sponsored

Quoteable Key Fact

"William B. Hayes filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 11 Jun 2025."

Quick Takeaways

  • This page summarizes William B. Hayes's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
  • 1 reported transaction and 1 derivative row are listed below.
  • Filing timestamp: 11 Jun 2025, 16:05.

What Changed

  • Previous filing in this sequence was filed on 03 Jun 2025.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hayes William B Director C/O INDAPTUS THERAPEUTICS, INC., 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK /s/ William B. Hayes 11 Jun 2025 0001320940

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +12,500 $0.000000 12,500 10 Jun 2025 Common Stock 12,500 $0.3300 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable on June 10, 2026.